AP3M1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.43710043865042E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.66080005303826E-09 |
Normal-vs-Stage2 |
1.425240E-04 |
Normal-vs-Stage3 |
2.49000042806813E-10 |
Normal-vs-Stage4 |
5.89619997271029E-09 |
Stage1-vs-Stage2 |
8.490400E-01 |
Stage1-vs-Stage3 |
5.175800E-02 |
Stage1-vs-Stage4 |
8.243700E-02 |
Stage2-vs-Stage3 |
2.962200E-01 |
Stage2-vs-Stage4 |
3.723600E-01 |
Stage3-vs-Stage4 |
8.690000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.46280012944555E-10 |
Normal-vs-AfricanAmerican |
1.5922999585527E-09 |
Normal-vs-Asian |
2.286800E-01 |
Caucasian-vs-AfricanAmerican |
2.165800E-01 |
Caucasian-vs-Asian |
2.625400E-01 |
AfricanAmerican-vs-Asian |
8.190000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.2385873416938E-12 |
Normal-vs-Female |
7.39030000529439E-08 |
Male-vs-Female |
1.658240E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.386500E-04 |
Normal-vs-Age(41-60Yrs) |
9.63680002463718E-09 |
Normal-vs-Age(61-80Yrs) |
4.05570022010693E-10 |
Normal-vs-Age(81-100Yrs) |
2.03289999999301E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.822000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.544400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.880000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.496600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.849400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.768400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.323600E-02 |
Normal-vs-Grade 2 |
3.5094999994989E-07 |
Normal-vs-Grade 3 |
1.7080781233858E-12 |
Normal-vs-Grade 4 |
3.12290004966798E-09 |
Grade 1-vs-Grade 2 |
5.097400E-01 |
Grade 1-vs-Grade 3 |
4.308500E-02 |
Grade 1-vs-Grade 4 |
7.980000E-02 |
Grade 2-vs-Grade 3 |
1.298400E-03 |
Grade 2-vs-Grade 4 |
3.151800E-02 |
Grade 3-vs-Grade 4 |
9.707600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.36460000036365E-07 |
Normal-vs-ccB subtype |
7.34930005741319E-10 |
ccA subtype-vs-ccB subtype |
3.620100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.9861000339082E-09 |
Normal-vs-N1 |
1.451770E-01 |
N0-vs-N1 |
4.842200E-01 |
|
|